OVERVIEW

TO BE THE GLOBAL LEADING THERAPEUTICS COMPANY

The ultimate goal of MDimune Inc. is to provide an innovative platform technology that can revolutionize the paradigm of human therapeutics by achieving target-specific delivery of effective drugs. The precision of this novel technology will enable safer and more effective treatments of many debilitating human diseases and bring hope to patients.

MORE VIEW

BUSINESS AREA

Therapeutics development using stem cell-derived vesicles

The innovative technology using stem cell-derived vesicles creates a synergy by combining regenerative potentials of stem cells with proven efficacies of various drugs loaded in the vesicles, presenting a novel path to many incurable human diseases

MORE VIEW >

Cancer therapeutics using immune cell-derived vesicles

The immune cell-derived, novel drug delivery system effectively carries many cytotoxic anticancer drugs to target tumors: in vitro and in vivo studies are underway using various anticancer drugs.

MORE VIEW >

Manufacturing and supply of BioDrone® reagents

We provide vesicles derived from immune or stem cells to biotech/pharmaceutical companies, facilitating the development of novel therapeutics delivering various drugs to desired target tissues.

MORE VIEW >

R&D

BIODRONE TECHNOLOGY

MDimune Inc. wishes to make a healthier and happier world by developing innovative therapeutics.